Literature DB >> 16183555

Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?

Yukio Kawahara1, Shin Kwak.   

Abstract

It has been repeatedly reported that spinal motor neurons are selectively vulnerable to AMPA receptor-mediated excitotoxicity. Therefore, identifying the uniqueness of AMPA receptors that are expressed on motor neurons, especially in individuals affected with sporadic amyotrophic lateral sclerosis (ALS) is essential for elucidating the etiology of this disorder. The mechanism that initiates motor neuronal death appears to be an exaggerated influx of Ca(2+) through AMPA receptors. The determinants that affect this Ca(2+) influx are Ca(2+) permeability, which is regulated by the presence of the GluR2 subunit and by RNA editing at the Q/R site of GluR2; channel desensitization, which is regulated by alternative splicing at the flip/flop site and by RNA editing at the R/G site of GluR subunits; and receptor density on the cell surface, which is controlled by many factors including regulatory proteins, direct phosphorylation and RNA editing at the Q/R site. This review focuses on recent progress on the molecular dynamics of AMPA receptors and discusses the pathophysiology of selective motor neuron death mediated by AMPA receptors in individuals affected with sporadic ALS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183555     DOI: 10.1080/14660820510037872

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  17 in total

Review 1.  A-to-I RNA editing and human disease.

Authors:  Stefan Maas; Yukio Kawahara; Kristen M Tamburro; Kazuko Nishikura
Journal:  RNA Biol       Date:  2006-01-12       Impact factor: 4.652

Review 2.  Glutamate and neurotrophic factors in neuronal plasticity and disease.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 3.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

4.  Mechanism of inhibition of the GluA2 AMPA receptor channel opening by talampanel and its enantiomer: the stereochemistry of the 4-methyl group on the diazepine ring of 2,3-benzodiazepine derivatives.

Authors:  Congzhou Wang; Li Niu
Journal:  ACS Chem Neurosci       Date:  2013-02-12       Impact factor: 4.418

5.  Water soluble RNA based antagonist of AMPA receptors.

Authors:  Mei Du; Henning Ulrich; Xiurong Zhao; Jaroslaw Aronowski; Vasanthi Jayaraman
Journal:  Neuropharmacology       Date:  2007-05-21       Impact factor: 5.250

6.  Transcript diversification in the nervous system: a to I RNA editing in CNS function and disease development.

Authors:  Aamira Tariq; Michael F Jantsch
Journal:  Front Neurosci       Date:  2012-07-09       Impact factor: 4.677

7.  The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain.

Authors:  Amanda Wright; Bryce Vissel
Journal:  Front Mol Neurosci       Date:  2012-04-11       Impact factor: 5.639

Review 8.  Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.

Authors:  Balapal S Basavarajappa; Ralph A Nixon; Ottavio Arancio
Journal:  Mini Rev Med Chem       Date:  2009-04       Impact factor: 3.862

Review 9.  Domoic acid toxicologic pathology: a review.

Authors:  Olga M Pulido
Journal:  Mar Drugs       Date:  2008-05-28       Impact factor: 5.118

10.  Mechanism of inhibition of the GluA1 AMPA receptor channel opening by the 2,3-benzodiazepine compound GYKI 52466 and a N-methyl-carbamoyl derivative.

Authors:  Andrew Wu; Congzhou Wang; Li Niu
Journal:  Biochemistry       Date:  2014-05-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.